Scott Friedman, MD
Dr. Friedman is Chief of Liver Diseases and Dean for Therapeutic Discovery at the Icahn School of Medicine at Mount Sinai. His pioneering research in hepatic fibrosis supported by NIH since 1986, combined with mentoring of over 80 trainees have contributed to the emergence of fibrosis as an exciting new therapeutic area in hepatology. Dr. Friedman was a Senior Fulbright Scholar at the Weizmann Institute, Israel in 1995 and President of the AASLD in 2009. He has received the International Hans Popper the EASL International Recognition Awards, the AASLD Distinguished Award and the American Liver Foundation Distinguished Award. Dr. Friedman is a Fellow of the AASLD, AGA, ACP and AAAS.